Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples